Global Pharmaceuticals & Biotech Most Popular Stocks

Instituto Rosenbusch

Market Cap: AR$5.9b

Manufactures and sells veterinary products in Argentina.

Medicamen Organics

Market Cap: ₹389.6m

Engages in the developing, manufacturing, and distribution of a range of pharmaceutical dosage in India and internationally.

BSF Enterprise

Market Cap: UK£3.3m

Develops and commercializes cutting-edge tissue-engineered solutions.

Spruce Biosciences

Market Cap: US$4.4m

A biopharmaceutical company focused on developing and commercializing novel therapies for neurological disorders.

Quoin Pharmaceuticals

Market Cap: US$4.4m

A late stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic products for rare and orphan diseases in the United States.

Genotech

Market Cap: ₩6.1b

Provides products and services for gene synthesis, genome analysis, and biopharmaceuticals in South Korea and internationally.

Raphael Pharmaceutical

Market Cap: US$4.3m

A pharmaceutical drug research and development company, focuses on the discovery and clinical development of life-improving drug therapies based on cannabinoids.

Nymox Pharmaceutical

Market Cap: US$4.3m

A biopharmaceutical company, engages in the research and development of products for the aging population.

Aditxt

Market Cap: US$4.2m

A commercial-stage company, discovers and develops products in the areas of immune health, precision health, population health, women’s health, and neurologic health.

Vilin Bio Med

Market Cap: ₹372.5m

Engages in the manufacture and trade of pharmaceutical products in India.

Biophytis

Market Cap: €3.6m

A clinical-stage biotechnology company, focuses on the development of therapeutics that slow the degenerative processes and improve functional outcomes for patients suffering from age-related diseases.

Rafarma Pharmaceuticals

Market Cap: US$4.2m

A multi-product pharmaceutical company, produces and sells drugs, generic antibiotics, and specialty pharmaceuticals in Russia.

Respiratorius

Market Cap: SEK 39.4m

A research company, develops drug candidates for the treatment of cancer, chronic obstructive pulmonary disease (COPD), and asthma.

Herbal Dispatch

Market Cap: CA$5.7m

Owns and operates cannabis e-commerce platforms in Canada and the United States.

Biodexa Pharmaceuticals

Market Cap: US$4.1m

A clinical stage biopharmaceutical company, focuses on developing a pipeline of products for the treatment of familial adenomatous polyposis, non-muscle invasive bladder cancer, and Type 1 diabetes and rare/orphan cancers of the brain.

Cannabis Poland

Market Cap: zł14.7m

Engages in the retail and wholesale of products based on hemp containing cannabidiol (CBD) in Poland.

Desh Rakshak Aushdhalaya

Market Cap: ₹357.2m

Engages in the manufacture and sale of ayurvedic and herbal products in India.

Veerhealth Care

Market Cap: ₹357.4m

Engages in manufacturing, marketing, and trading of ayurvedic medicines in India.

Reflect Scientific

Market Cap: US$4.0m

Through its subsidiaries, engages in the design, development, and sale of scientific equipment for the life science and manufacturing industries worldwide.

Euroespes

Market Cap: €3.7m

Euroespes, S.A., a medical center, provides medical services for the research, diagnosis, and treatment of central nervous system disorders and other diseases in Spain and internationally.

Burzynski Research Institute

Market Cap: US$3.9m

Engages in the research and development of antineoplaston drugs for the treatment of various cancers.

Nuformix

Market Cap: UK£2.9m

Together with its subsidiary, Nuformix Technologies Limited, operates in the field of pharmaceutical development for treating fibrosis and oncology through drug repurposing in the United Kingdom.

Société des Industries Pharmaceutiques de Tunisie -

Market Cap: د.ت11.2m

Société des Industries Pharmaceutiques de Tunisie - S.A.

Bone Biologics

Market Cap: US$3.8m

A medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein.

MYND Life Sciences

Market Cap: CA$5.2m

A life sciences-based neuro-pharmaceutical drug development company, advances medicines based on neuro-anti-inflammatory substances for depressive disorders through science and clinical trials in Canada and the United States.

Applied DNA Sciences

Market Cap: US$3.8m

A biotechnology company, develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) in the Americas, Europe, Asia, and internationally.

Theriva Biologics

Market Cap: US$3.7m

A clinical-stage company, develops therapeutics to treat cancer and related diseases in areas of high unmet need in the United States.

Acrux

Market Cap: AU$5.7m

Develops and commercializes generic and topically applied pharmaceutical products in Australia, Europe, the United States, and internationally.

S.C. Sintofarm

Market Cap: RON 16.6m

Develops pharmaceutical products in Romania.

Vineet Laboratories

Market Cap: ₹326.4m

Engages in the research, development, manufacture, and sale of active pharmaceutical ingredients (API), intermediates, and fine chemicals in India.

Gujarat Terce Laboratories

Market Cap: ₹325.5m

Develops, manufactures, markets, and distributes medicines and healthcare products in India and internationally.

Indaptus Therapeutics

Market Cap: US$3.6m

A clinical biotechnology company, develops various anti-cancer and anti-viral immunotherapy products.

StageZero Life Sciences

Market Cap: CA$4.9m

A vertically integrated healthcare company, develops and commercializes proprietary molecular diagnostic tests for the early detection of diseases and personalized health management with a primary focus on cancer-related indications in North America and Western Europe.

FinCanna Capital

Market Cap: CA$5.0m

Does not have significant operations.

1933 Industries

Market Cap: CA$5.0m

Engages in the cultivation, extraction, and production of cannabis products in the United States.

Panjon

Market Cap: ₹312.6m

Manufactures and trades in consumer and pharmaceutical products in India.